|3rd March 2021||Jeffrey E. Eberwein||1,000||Open or private purchase||$14.06||$14,060.00|
|1st March 2021||Jeffrey E. Eberwein||7||Open or private purchase||$15.25||$106.75|
|28th February 2021||Martin B Shirley||82||Payment by withholding||$3.38||$277.16|
|28th February 2021||Matthew G. Molchan||470||Payment by withholding||$3.38||$1,588.60|
|28th February 2021||Matthew G. Molchan||1,327||Exercise of derivative||$0.00|
|28th February 2021||Matthew G. Molchan||1,049||Exercise of derivative||$0.00|
|28th February 2021||Matthew G. Molchan||372||Payment by withholding||$3.38||$1,257.36|
|28th February 2021||Martin B Shirley||350||Exercise of derivative||$0.00|
|28th February 2021||Martin B Shirley||104||Payment by withholding||$3.38||$351.52|
|28th February 2021||Martin B Shirley||276||Exercise of derivative||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.
Digirad Corp. engages in the provision of mobile healthcare solutions. It operates through the following segments: Diagnostic Services, Mobile Healthcare, and Diagnostic Imaging. The Mobile Healthcare segment provides contract diagnostic imaging, including computerized tomography, magnetic resonance imaging, positron emission tomography and healthcare expertise to hospitals. The Diagnostic imaging segment develops solid-state gamma cameras, imaging systems and camera maintenance contracts.